| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 491.7 | 437.7 | 475.4 |
| Other income | 5.5 | 6.2 | 4.9 |
| Total income | 497.2 | 443.9 | 480.3 |
| Profit before exceptional items & tax | 157.7 | 112.3 | 129.6 |
| Exceptional items | 0.0 | 0.0 | -27.3 |
| Profit before tax | 157.7 | 112.3 | 102.3 |
| Net profit | 116.7 | 83.5 | 76.0 |
| Operating margin | 31.7% | 25.3% | 21.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +53.60% |
|---|---|
| Net profit, quarter on quarter | +39.80% |
| Revenue, year on year | +3.40% |
| Operating profit, year on year | +22.10% |
| Operating profit, quarter on quarter | +43.40% |
BSE results filing, NSE: SANOFI. Figures extracted from the filing.
Sanofi India Ltd: key numbers
- Share price
- ₹3,202.00
- Market cap
- ₹7,374 Cr
- Revenue (annual)
- ₹1,837 Cr
- Net profit (annual)
- ₹326.7 Cr
- P/E (TTM)
- 22.8×Sector 46.1×
- Promoter holding
- 60.40%+0.00% QoQ
- FII holding
- 5.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sanofi India Ltd
All →Sanofi India Dividend
Sanofi India declared an interim dividend of Rs 75 per equity share at its 29-Oct-2026 board meeting. Record date is 5-Nov-2026.
Sanofi India Other Announcement
Sanofi India Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Sanofi India Board Meeting Date
Sanofi India will hold a board meeting on 29th October 2026 to consider unaudited financial results and a potential interim dividend for FY 2026.
Sanofi India Promoter Buying (Off-Market): ₹1,068 Cr
Sanofi Healthcare India acquired 3.5 million shares (15.20%) from Hoechst GmbH in a promoter-group block deal at ₹3,052/share. Total promoter stake unchanged at 60.40%.
- Value
- ₹1,068 Cr
- Promoter stake change
- +15.20%
Sanofi India Legal & Regulatory
Sanofi India received a GST show cause notice from Ahmedabad authorities for FY 2022-23. The notice proposes a tax, interest, and penalty demand totaling Rs.16.40 Crore.
- Value
- ₹16.40 Cr
Sanofi India Promoter Selling (Off-Market): ₹1,068 Cr
Sanofi India promoter Hoechst GmbH sold 35,00,000 equity shares for ₹1,068.20 Crore. The transaction was an inter-se transfer via block deal, reducing its stake to 45.18%.
- Value
- ₹1,068 Cr